Re-inventing tumor targeting

Best-in-class, TSL-based tumor targeting.
Explore the science behind Thermosome’s tumor targeting
Setting a new standard for the treatment of locally advanced soft tissue sarcoma.
Explore Thermosome’s pipeline
Experienced team of biotech entrepreneurs.
Get to know Thermosome’s team

Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.

Latest news

Thermosome announces the appointment of Dr. Sabine Hauck as Chief Technology Officer (CTO)

Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001

Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board

more news

Upcoming event

ESMO Congress

September 13–17, 2024
Barcelona, Spain


more Events